Clinical Trial Update: Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity

View source ↗

Summary

A recruiting clinical trial seeks to estimate the risk of respiratory infections associated with CFTR heterozygosity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infections

Snippet

Sponsor: Philip Polgreen | Conditions: Carrier State, Respiratory Infections | Status: RECRUITING